Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Dec 01, 2006 (Vol. 26, No. 21)

International Council on Nanotechnology

  • News, database
  • Not very inspired
From the URL, I thought I had stumbled on an agricultural icon site, but a glance at the title showed me to be wrong (again!). The “International Council on Nanotechnology” (ICON) is a partnership for nanotechnology stewardship and sustainability with global participants from industry, government, academia, and other organizations. The group (organized at Rice University) has goals of communicating environmental and health risks of nanotechnology with an aim to sound, responsible risk management. If you’re a policy wonk, you’ll probably enjoy wading through the various organizational statements. If you’re not, you can still enjoy the offerings of the site’s newsroom, research paper database, glossary, or links.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »